MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.550
+0.080 (2.31%)
Dec 3, 2025, 4:00 PM EST - Market closed
MDxHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 103.07 | 90.05 | 70.19 | 37.05 | 22.24 | 18.46 | Upgrade | |
Revenue Growth (YoY) | 21.68% | 28.29% | 89.43% | 66.62% | 20.47% | 56.64% | Upgrade |
Cost of Revenue | 36.61 | 34.91 | 26.26 | 17.84 | 11.68 | 10.42 | Upgrade |
Gross Profit | 66.46 | 55.14 | 43.93 | 19.22 | 10.56 | 8.04 | Upgrade |
Selling, General & Admin | 65.43 | 63.78 | 59.93 | 49.01 | 31.37 | 30.74 | Upgrade |
Research & Development | 9.86 | 10.55 | 6.38 | 5.45 | 5.59 | 4.27 | Upgrade |
Amortization of Goodwill & Intangibles | 5.27 | 4.91 | 4.49 | 3.17 | 1.61 | - | Upgrade |
Other Operating Expenses | -0.35 | 0.62 | 0.46 | 0.07 | -0.12 | -0.12 | Upgrade |
Operating Expenses | 80.22 | 79.86 | 71.26 | 57.71 | 38.45 | 34.89 | Upgrade |
Operating Income | -13.75 | -24.72 | -27.33 | -38.49 | -27.88 | -26.85 | Upgrade |
Interest Expense | -12.18 | -7.63 | -5.58 | -2.64 | -1.88 | -1.35 | Upgrade |
Interest & Investment Income | 0.68 | 1.08 | 1.09 | 0.13 | 0.01 | 0 | Upgrade |
Other Non Operating Income (Expenses) | 0.62 | 0.62 | -2.12 | -0.19 | -0.1 | -0.19 | Upgrade |
EBT Excluding Unusual Items | -24.64 | -30.66 | -33.95 | -41.19 | -29.85 | -28.39 | Upgrade |
Asset Writedown | - | - | - | -0.04 | - | -0.27 | Upgrade |
Other Unusual Items | -7.03 | -7.03 | -9.15 | -2.81 | 0.85 | - | Upgrade |
Pretax Income | -31.67 | -37.69 | -43.1 | -44.04 | -29 | -28.66 | Upgrade |
Income Tax Expense | -0.24 | 0.38 | 0 | - | - | - | Upgrade |
Net Income | -31.43 | -38.07 | -43.1 | -44.04 | -29 | -28.66 | Upgrade |
Net Income to Common | -31.43 | -38.07 | -43.1 | -44.04 | -29 | -28.66 | Upgrade |
Shares Outstanding (Basic) | 49 | 33 | 26 | 16 | 12 | 8 | Upgrade |
Shares Outstanding (Diluted) | 49 | 33 | 26 | 16 | 12 | 8 | Upgrade |
Shares Change (YoY) | 80.01% | 26.82% | 63.31% | 30.12% | 46.56% | 32.95% | Upgrade |
EPS (Basic) | -0.64 | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 | Upgrade |
EPS (Diluted) | -0.64 | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 | Upgrade |
Free Cash Flow | -6.98 | -19.72 | -24.24 | -36.91 | -23.44 | -20.78 | Upgrade |
Free Cash Flow Per Share | -0.14 | -0.60 | -0.94 | -2.33 | -1.92 | -2.50 | Upgrade |
Gross Margin | 64.48% | 61.23% | 62.58% | 51.87% | 47.50% | 43.58% | Upgrade |
Operating Margin | -13.34% | -27.45% | -38.93% | -103.87% | -125.37% | -145.45% | Upgrade |
Profit Margin | -30.50% | -42.28% | -61.40% | -118.86% | -130.41% | -155.27% | Upgrade |
Free Cash Flow Margin | -6.77% | -21.90% | -34.54% | -99.60% | -105.42% | -112.57% | Upgrade |
EBITDA | -7.07 | -18.96 | -22.18 | -33.58 | -24.85 | -24.29 | Upgrade |
EBITDA Margin | -6.86% | -21.05% | -31.59% | -90.62% | -111.72% | -131.58% | Upgrade |
D&A For EBITDA | 6.69 | 5.77 | 5.15 | 4.91 | 3.04 | 2.56 | Upgrade |
EBIT | -13.75 | -24.72 | -27.33 | -38.49 | -27.88 | -26.85 | Upgrade |
EBIT Margin | -13.34% | -27.45% | -38.93% | -103.87% | -125.37% | -145.45% | Upgrade |
Revenue as Reported | - | - | - | - | 22.24 | 18.46 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.